Aadi Bioscience, Inc logo

Aadi Bioscience, Inc

Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers.

69 employees · est. 2011 · Los Angeles, United States

VS
NeoPhore Ltd logo

NeoPhore Ltd

Discovering drugs that create neoantigens

18 employees · est. 2017 · Cambridge, United Kingdom

Aadi Bioscience, Inc is the older company (2011 vs 2017); Aadi Bioscience, Inc is the larger of the two.

Side-by-Side Comparison

Aadi Bioscience, Inc NeoPhore Ltd
Founded
2011 older 2017
Headquarters
Los Angeles, United States Cambridge, United Kingdom
Employees
69 larger 18
Industry
Biopharma, Biotechnology, Life Sciences Biotechnology, Health and Wellness
Funding Stage
Post Ipo Equity Series B
Total Funding
$250.50M $33.80M
Funding Rounds
3 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical, Precision Therapy, MTOR Inhibition, Genetically-defined Cancers, Nanoparticle Technology, FDA-approved Drug, PEComa, Cancer Therapy, Leadership Team, Precision Medicine, Patient-centric Approach, MTOR Pathway, Oncology, Clinical Development, Precision Oncology Immuno-oncology, Small Molecule Therapeutics, Neoantigen Creation, Genetic Mechanisms, Cancer Immunotherapy, Immune System Stimulation, Cancer Treatment, Drug Development, Cancer Therapy, Clinical Validation, Lab Studies, Oncology, Drug Targeting, Patient Outcomes, Cancer Research
Website
aadibio.com neophore.com
Aadi Bioscience, Inc logo

About Aadi Bioscience, Inc

Aadi Bioscience, Inc. is a commercial-stage biopharmaceutical company with a focus on precision therapies for genetically-defined cancers. The company leverages precision medicine and nanoparticle technology to maximize the potential of mTOR inhibition, aiming to offer transformative therapies to ca...

NeoPhore Ltd logo

About NeoPhore Ltd

NeoPhore Ltd is a biotechnology startup headquartered in the United Kingdom, founded in 2017. The company's focus is on creating novel small molecule immuno-oncology therapeutics. Their drugs target genetic mechanisms that have been validated in both clinical and lab studies for promoting neoantigen...

We will tell you when either one moves

BounceWatch watches Aadi Bioscience, Inc and NeoPhore Ltd for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Aadi Bioscience, Inc and NeoPhore Ltd — by email.

Frequently Asked Questions

Aadi Bioscience, Inc — Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers.. NeoPhore Ltd — Discovering drugs that create neoantigens. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Aadi Bioscience, Inc has raised $250.50M while NeoPhore Ltd has raised $33.80M.
Aadi Bioscience, Inc and NeoPhore Ltd operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Aadi Bioscience, Inc with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Aadi Bioscience, Inc on 12 Sep 2024, and NeoPhore Ltd on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy